Sistilli Carlo 4
4 · Edesa Biotech, Inc. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
Sistilli Carlo
Director
Transactions
- Award
Common Shares
2025-02-12$1.92/sh+10,416$19,999→ 10,416 total
Holdings
- 522(indirect: Held by York-Cav Enterprises, Inc.)
Common Shares
Footnotes (3)
- [F1]On February 12, 2025, the Reporting Person purchased in a private placement, 10,416 common shares, without par value, of the Issuer, for a purchase price of $1.92 per share.
- [F2]Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023.
- [F3]York-Cav Enterprises, Inc. is partially owned by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.